CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-09 | SEIDENBERG BETH C Director | Other disposition | −247,446 | 17,162 | ||
| 2023-06-09 | SEIDENBERG BETH C Director | Other acquisition | +6,656 | 25,926 | ||
| 2023-06-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +16,000 | $3.95 | $63K | 231,924 |
| 2023-06-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −10,131 | $40.61 | $411K | 221,793 |
| 2023-06-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −5,869 | $41.59 | $244K | 215,924 |
| 2023-06-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,533 | $40.61 | $103K | 18,064 |
| 2023-06-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,467 | $41.59 | $61K | 16,597 |
| 2023-06-07 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −16,000 | 795,556 | ||
| 2023-06-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +16,000 | $3.95 | $63K | 231,924 |
| 2023-06-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −7,514 | $40.65 | $305K | 224,410 |
| 2023-06-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,486 | $41.32 | $351K | 215,924 |
| 2023-06-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,879 | $40.65 | $76K | 22,718 |
| 2023-06-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −2,121 | $41.32 | $88K | 20,597 |
| 2023-06-06 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −16,000 | 811,556 | ||
| 2023-06-05 | Schlanger David J Executive Chairman | Exercise or conversion 10b5-1 | +41,666 | $0.91 | $38K | 115,153 |
| 2023-06-05 | Schlanger David J Executive Chairman | Sale 10b5-1 | −9,530 | $39.21 | $374K | 105,623 |
| 2023-06-05 | Schlanger David J Executive Chairman | Sale 10b5-1 | −32,136 | $40.24 | $1.3M | 73,487 |
| 2023-06-05 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −41,666 | 357,228 | ||
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion 10b5-1 | +16,000 | $3.95 | $63K | 231,924 |
| 2023-06-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,629 | $39.19 | $142K | 228,295 |
Page 21 of 77 · 1,524 trades